RS65118B1 - Farmaceutske supstance koje obuhvataju inhibitor janus kinaze (jak) - Google Patents
Farmaceutske supstance koje obuhvataju inhibitor janus kinaze (jak)Info
- Publication number
- RS65118B1 RS65118B1 RS20240079A RSP20240079A RS65118B1 RS 65118 B1 RS65118 B1 RS 65118B1 RS 20240079 A RS20240079 A RS 20240079A RS P20240079 A RSP20240079 A RS P20240079A RS 65118 B1 RS65118 B1 RS 65118B1
- Authority
- RS
- Serbia
- Prior art keywords
- pharmaceutical compositions
- jak inhibitor
- jak
- inhibitor
- pharmaceutical
- Prior art date
Links
- 229940122245 Janus kinase inhibitor Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762471171P | 2017-03-14 | 2017-03-14 | |
| US201762536614P | 2017-07-25 | 2017-07-25 | |
| EP18713553.8A EP3595667B1 (en) | 2017-03-14 | 2018-03-12 | Pharmaceutical compositions comprising a jak inhibitor |
| PCT/US2018/022027 WO2018169875A1 (en) | 2017-03-14 | 2018-03-12 | Pharmaceutical compositions comprising a jak inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS65118B1 true RS65118B1 (sr) | 2024-02-29 |
Family
ID=61768547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20240079A RS65118B1 (sr) | 2017-03-14 | 2018-03-12 | Farmaceutske supstance koje obuhvataju inhibitor janus kinaze (jak) |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US20180263997A1 (sr) |
| EP (2) | EP4368173A3 (sr) |
| JP (2) | JP6979080B2 (sr) |
| KR (2) | KR102303052B1 (sr) |
| CN (2) | CN110418644A (sr) |
| AU (2) | AU2018236156A1 (sr) |
| BR (1) | BR102018004952A2 (sr) |
| CA (1) | CA3055955C (sr) |
| DK (1) | DK3595667T3 (sr) |
| ES (1) | ES2969519T3 (sr) |
| FI (1) | FI3595667T3 (sr) |
| HR (1) | HRP20240112T1 (sr) |
| HU (1) | HUE065239T2 (sr) |
| JO (1) | JOP20180018A1 (sr) |
| LT (1) | LT3595667T (sr) |
| PL (1) | PL3595667T3 (sr) |
| PT (1) | PT3595667T (sr) |
| RS (1) | RS65118B1 (sr) |
| SI (1) | SI3595667T1 (sr) |
| TW (1) | TWI670270B (sr) |
| UY (1) | UY37632A (sr) |
| WO (1) | WO2018169875A1 (sr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201808575D0 (en) * | 2018-05-24 | 2018-07-11 | Galapagos Nv | Methods for the treatment of psoriatic arthrits |
| US20220072002A1 (en) * | 2018-12-24 | 2022-03-10 | Chia Tai Tianqing Pharmaceuticalgroup Co., Ltd. | Treatment use of pyrrolopyrimidine compound, and solid pharmaceutical composition of pyrrolopyrimidine compound |
| WO2020177705A1 (zh) * | 2019-03-05 | 2020-09-10 | 苏州科睿思制药有限公司 | Filgotinib的马来酸盐晶型CSI及其制备方法和用途 |
| WO2021044327A1 (en) * | 2019-09-03 | 2021-03-11 | Dr. Reddy's Laboratories Limited | Solid forms of filgotinib maleate and processes thereof |
| CN111672456A (zh) * | 2020-06-18 | 2020-09-18 | 贵州大学 | 一种新型球-棒结构的介孔Janus纳米粒子及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI462920B (zh) | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | 用於治療退化性及發炎疾病之新穎化合物 |
| GB201402070D0 (en) * | 2014-02-07 | 2014-03-26 | Galapagos Nv | Pharmaceutical compositions for the treatment of inflammatory disorders |
| GB201402071D0 (en) * | 2014-02-07 | 2014-03-26 | Galapagos Nv | Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| WO2017012770A1 (en) * | 2015-07-23 | 2017-01-26 | Ratiopharm Gmbh | Acid addition salts of filgotinib |
-
2017
- 2017-03-14 JO JOP/2018/0018A patent/JOP20180018A1/ar unknown
-
2018
- 2018-03-12 AU AU2018236156A patent/AU2018236156A1/en not_active Abandoned
- 2018-03-12 SI SI201831050T patent/SI3595667T1/sl unknown
- 2018-03-12 WO PCT/US2018/022027 patent/WO2018169875A1/en active Application Filing
- 2018-03-12 CN CN201880018328.2A patent/CN110418644A/zh active Pending
- 2018-03-12 FI FIEP18713553.8T patent/FI3595667T3/fi active
- 2018-03-12 KR KR1020197029508A patent/KR102303052B1/ko active IP Right Grant
- 2018-03-12 US US15/918,765 patent/US20180263997A1/en not_active Abandoned
- 2018-03-12 CN CN202310082905.7A patent/CN116059211A/zh active Pending
- 2018-03-12 HU HUE18713553A patent/HUE065239T2/hu unknown
- 2018-03-12 LT LTEPPCT/US2018/022027T patent/LT3595667T/lt unknown
- 2018-03-12 EP EP23208646.2A patent/EP4368173A3/en active Pending
- 2018-03-12 DK DK18713553.8T patent/DK3595667T3/da active
- 2018-03-12 ES ES18713553T patent/ES2969519T3/es active Active
- 2018-03-12 PL PL18713553.8T patent/PL3595667T3/pl unknown
- 2018-03-12 PT PT187135538T patent/PT3595667T/pt unknown
- 2018-03-12 EP EP18713553.8A patent/EP3595667B1/en active Active
- 2018-03-12 RS RS20240079A patent/RS65118B1/sr unknown
- 2018-03-12 KR KR1020217029180A patent/KR102425226B1/ko active IP Right Grant
- 2018-03-12 CA CA3055955A patent/CA3055955C/en active Active
- 2018-03-12 JP JP2019550213A patent/JP6979080B2/ja active Active
- 2018-03-12 HR HRP20240112TT patent/HRP20240112T1/hr unknown
- 2018-03-13 TW TW107108404A patent/TWI670270B/zh active
- 2018-03-13 BR BR102018004952A patent/BR102018004952A2/pt active Search and Examination
- 2018-03-14 UY UY0001037632A patent/UY37632A/es not_active Application Discontinuation
-
2021
- 2021-01-15 AU AU2021200229A patent/AU2021200229B2/en active Active
- 2021-02-26 US US17/186,446 patent/US11975008B2/en active Active
- 2021-09-16 JP JP2021150706A patent/JP2022003053A/ja active Pending
-
2024
- 2024-04-05 US US18/628,560 patent/US20240277725A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL271657A (en) | medical preparation | |
| EP3248980C0 (en) | JAK INHIBITOR | |
| IL269061A (en) | A pharmaceutical preparation containing Selexifag | |
| PT3595667T (pt) | Composições farmacêuticas compreendendo um inibidor de jak | |
| HK1259440A1 (zh) | 包含btk抑制劑的配製品/組合物 | |
| IL271759B1 (en) | Pharmaceutical preparations that include anthraxtinib | |
| GB201608323D0 (en) | Pharmaceutical compositions | |
| HK1259441A1 (zh) | 包含btk抑制劑的製劑/組合物 | |
| GB201705303D0 (en) | Pharmaceutical compositions | |
| SG11202001179YA (en) | Pharmaceutical compositions | |
| GB201804548D0 (en) | Pharmaceutical compositions | |
| GB201705305D0 (en) | Pharmaceutical compositions | |
| GB201705306D0 (en) | Pharmaceutical compositions | |
| GB201705304D0 (en) | Pharmaceutical compositions | |
| GB202007031D0 (en) | Aerosol compositions | |
| GB201808571D0 (en) | Pharmaceutical compositions | |
| IL263999A (en) | Pharmaceutical compositions | |
| GB201808567D0 (en) | Pharmaceutical compositions | |
| IL272044A (en) | Pharmacy preparations | |
| ZA202000014B (en) | Pharmaceutical compositions | |
| ZA201705782B (en) | Pharmaceutical compositions | |
| IL272428A (en) | pharmaceutical preparations | |
| ZA201801904B (en) | A pharmaceutical composition | |
| GB201715881D0 (en) | New pharmaceutical compositions | |
| GB201810261D0 (en) | New pharmaceutical compositions |